Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Clinical trial NCT01332227 · COMPLETED

Trial details

NCT number: NCT01332227
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV, Combination Therapy

Start date: 2011-10-01
Primary completion: 2013-09-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.